ArticleImmunoTargets and therapy2026

Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma.

Suiping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.